Moreover, no difference in CDKN2C expression between various SCLC stages (p > 0.05; Additional file 3A), to some extent suggesting that the prognosis of CDKN2C mRNA expression in SCLC was not affected by SCLC stages. This evidence concerns the gene CDKN2C and small cell lung carcinoma.